Palonosetron Hydrochloride — CAS 135729-62-3

Palonosetron Hydrochloride is a second-generation 5-HT3 receptor antagonist with a high binding affinity and prolonged plasma half-life compared to first-generation agents. It is used for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
• Prevention of post-operative nausea and vomiting (PONV)
• Management of nausea in patients receiving moderately to highly emetogenic chemotherapy
• Second-generation 5-HT3 antagonist in oncology supportive care

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support